but in whom no deletion could be detected may have a mutation in a single candidate gene that is primarily responsible for the phenotype.
We identified three such individuals without detectable deletions involving 17p11.2. These individuals were all residents at a facility that has diagnosed over two dozen individuals with SMS and is well known for its work in describing the clinical phenotype. All three individuals were evaluated clinically through the facility's genetics department on multiple occasions (Table 1 and Supplementary Note 1 online). Based on a strong clinical suspicion of SMS, we received samples for further analysis when initial cytogenetics and fluorescence in situ hydridization (FISH) studies for the 17p11.2 deletion were negative. These three individuals, SMS129, SMS156 and SMS159, have many of the typical features of SMS, including craniofacial abnormalities, sleep disturbances and characteristic behaviors, such as onychotillomania (selfmutilation of finger-and toenails), polyembolokoilomania (insertion of foreign objects into body orifices), spasmodic self-hugging and explosive aggressive episodes (Table 1) . These individuals were further evaluated for sub-microscopic deletions in 17p11.2 using an extensive series of FISH probes that span the SMS critical region (see Supplementary Note 2 online). Although our FISH analyses do not eliminate the possibility of a small, cryptic deletion in 17p11.2, they do confirm that individuals SMS129, SMS156 and SMS159 do not have deletions of the SMS critical region.
Next we undertook systematic sequencing of genes in individual SMS129 beginning with three genes localized to the SMS critical interval 4, 6, 8 : developmentally regulated GTP binding protein 2 (DRG2), RAS dexamethasone-induced 1 (RASD1) and retinoic acid induced 1 (RAI1). We identified no mutations in either RASD1 or DRG2 but found a deletion of 29 bp in exon 3 of RAI1 on one allele in individual SMS129 (Fig. 1b) . This deletion was clearly evident as two bands resolved on a 2% agarose gel representing the deleted and non-deleted alleles (Fig. 1b) . The deletion produces a frameshift (Fig. 1b) that introduces eight incorrect amino acids followed by a stop codon, truncating the protein. We predict that this deleted allele encodes a truncated and either abnormally functioning or non-functioning RAI1 protein, probably resulting in haploinsufficiency for RAI1.
We then examined individuals SMS156 and SMS159 for mutations in RAI1. In both individuals we identified a deletion on one allele of a single cytosine in a run of Cs (Fig. 1c,d) . In individual SMS156, the deleted C occurred in a run of six Cs ending at nucleotide position 4,929 of the RAI1 mRNA. This 4929delC on the coding strand produces a frameshift, introducing 74 incorrect amino acids and truncating the protein (Fig. 1c) . Similarly, we found a deletion on one allele of a single cytosine in a run of four Cs ending at nucleotide position 1,308 in exon 3 of the RAI1 (Fig. 1d) in individual SMS159. This deletion also causes a frameshift that incorporates 34 incorrect amino acids beginning at aminoacid position 437, followed by a stop codon and truncation of the protein. None of the parents of these individuals carried any of these mutations (Fig. 1a-c and data not shown), although we cannot rule out mosaicism in the germ cells. We also screened 200 control chromosomes from individuals of European descent and did not detect these mutations in this population (data not shown). The genomic structure of RAI1 and location of the three mutations in the primary transcript are shown in Figure 1e . (See Supplementary Note 3 for the complete RAI1 sequence.)
RAI1 is a novel gene whose cellular role is still unclear. Rai1 was first identified in mouse carcinoma cells when it was upregulated following treatment with retinoic acid 10 . It is possible that Rai1 is involved in neuronal differentiation, as in situ and immunocytochemistry analysis of adult mouse brain showed that the Rai1 transcript and protein product are localized to neurons 10 . The RAI1 protein, which contains regions of sequence similarity to the transcriptional coactivator TCF20 (refs. 11,12) , may also be localized to the nucleus and stimulate transcription. Our sequence analysis shows that human RAI1 contains a putative bipartite nuclear localization signal beginning at amino-acid positions 1,113 and 1,176 and predicted N-glycosylation sites. As no known DNAbinding motifs have been identified, RAI1 may interact with other DNA-binding proteins to exert its effects on transcription. These processes may be evolutionarily conserved, as the RAI1 protein has approximately 77% overall identity to the mouse Rai1 protein 12 and putative RAI1 expressed-sequence tag (EST) homologs have been sequenced from Rattus norvegicus, Bos taurus and Xenopus laevis.
We suggest that SMS may be similar to previously described microdeletion syndromes in which a single gene is implicated in most of the features but other deleted genes may modify the overall phenotype [13] [14] [15] . Haploinsufficiency of RAI1 is probably responsible for the behavioral, neurological, otolaryngological and craniofacial aspects of this syndrome, but more variable features such as heart and renal defects are probably due to hemizygosity of other genes in the 17p11.2 region. Finally, we advocate the use of genomic probes that contain RAI1, such as RPCI-1 253P07, for use in FISH to screen individuals who may have SMS. In individuals with strong clinical features and negative FISH analysis, mutation screening may prove informative.
Accession numbers. Human RAI1 mRNA, GenBank AJ271790; human RAI1 protein, GenProt CAC20423; human RAI1 genomic region, GenBank AJ271791 and NT_030843; bc915D19, GenBank AC080148; bc384M20, GenBank AC087163; pc253P07, GenBank AL354000; pc178F10, GenBank AL035367; bc189D22, GenBank AC099988; RAI1 transcript variant KIAA1802, GenBank AB058723. Mouse Rai1 mRNA, GenBank NM_009021; mouse Rai1 protein, NP_033047. Putative RAI1 EST homologs from R. norvegicus, GenBank BU758552; B. taurus, GenBank BE667697; and X. laevis, GenBank BG813716. Human TCF20 mRNA, GenBank XM_040067; mouse Tcf20, GenBank NM_013836. 
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